H.R. 8633

H.R. 8633: To specify the standards governing claims of consciously parallel pricing coordination in civil actions under the Sherman Act, and to clarify the meaning of contract, combination in the form of trust or otherwise, or conspiracy under the Sherm

Introduced Mary Scanlon (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8633 aims to establish clear standards for evaluating claims of consciously parallel pricing coordination in civil lawsuits under the Sherman Act. It seeks to clarify the definitions of terms like 'contract,' 'combination,' and 'conspiracy' as they relate to antitrust laws, potentially impacting how courts handle cases involving alleged price-fixing or collusion among companies.

Positive Media Summary

Supporters of H.R. 8633 argue that the bill will provide much-needed clarity in antitrust litigation, helping to prevent frivolous lawsuits and ensuring that legitimate claims are evaluated fairly. They believe that clearer standards will foster a more competitive marketplace by distinguishing between lawful business practices and unlawful collusion.

Negative Media Summary

Critics of H.R. 8633 express concern that the bill may undermine antitrust enforcement by making it more difficult to prove cases of price-fixing and collusion. They argue that the proposed standards could protect companies engaging in anti-competitive behavior and hinder efforts to maintain fair competition in the market.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Commerce

The analysis of H.R. 8633 indicates no direct industry overlaps between the sponsor, Mary Scanlon, and her top donor industries. The bill focuses on standards governing claims of pricing coordination under the Sherman Act, which does not appear to directly relate to the interests of her top donors. The lobbying activity in this policy area includes various entities, but the disclosed amounts are limited, with only SANA HEALTH contributing $7,500. The remaining lobbying activities are undisclosed, making it difficult to assess any direct influence. Overall, the lack of direct industry connections and the limited financial contributions suggest a low risk of conflict of interest for voters to consider.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
SPHERE LABS TERRAPIN STRATEGY, INC $22,000
ATZ MANUFACTURING TERRAPIN STRATEGY, INC $21,750
THE PRESIDENTS' FORUM OF THE DISTILLED SPIRITS INDUSTRY THE PRESIDENTS' FORUM OF THE DISTILLED SPIRITS INDUSTRY $20,000
SANA HEALTH TERRAPIN STRATEGY, INC $7,500
NEBRASKA RURAL GENERATION LLC JABAL COMPANIES LLC undisclosed
RHOBACK, INC. ATLAS CROSSING LLC undisclosed
GLOBAL MOBILE SOFTWARE LLC TERRAPIN STRATEGY, INC undisclosed
SUMAIR VIRANI COZEN O'CONNOR PUBLIC STRATEGIES undisclosed
NATIONAL STRUCTURED SETTLEMENTS TRADE ASSOCIATION COZEN O'CONNOR PUBLIC STRATEGIES undisclosed
NUMERACLE, INC. ACG ADVOCACY undisclosed
AMERICAN COUNCIL FOR CAPITAL FORMATION AMERICAN COUNCIL FOR CAPITAL FORMATION undisclosed
HUBBARD HOUSE RESTAURANT, LLC COZEN O'CONNOR PUBLIC STRATEGIES undisclosed
INTUIT INC., AND ITS ENTERPRISE MEMBERS COZEN O'CONNOR PUBLIC STRATEGIES undisclosed
NATIONAL CENTER OF SEXUAL EXPLOITATION (NCOSE) ACG ADVOCACY undisclosed
SHARED ECONOMY SERVICES, LLC TERRAPIN STRATEGY, INC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Mary Scanlon, ranked by total contributions.

Health Professionals $80,000,000
Individuals: $80,000,000 PACs: $0
Retired $25,000,000
Individuals: $25,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us